Page 26 - AN-3-2

Advanced Neurology Fatigue management in patients with MS

22. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, 2020;46:102586.
Schlech WF. Measuring the functional impact of fatigue: doi: 10.1016/j.msard.2020.102586
Initial validation of the fatigue impact scale. Clin Infect Dis.
1994;18(Suppl 1):S79-S83. 33. Fitzgerald KC, Morris B, Soroosh A, et al. Pilot randomized
active-placebo-controlled trial of low-dose ketamine for the
doi: 10.1093/clinids/18.Supplement_1.S79
treatment of multiple sclerosis-related fatigue. Mult Scler J.
23. Tarasiuk J, Kapica-Topczewska K, Czarnowska A, 2021;27(6):942-953.
Chorąży M, Kochanowicz J, Kułakowska A. Co-occurrence
of fatigue and depression in people with multiple sclerosis: doi: 10.1177/1352458520936226
A mini-review. Front Neurol. 2022;12:817256. 34. Morrow SA, Rosehart H, Johnson AM. The effect of
Fampridine-SR on cognitive fatigue in a randomized
doi: 10.3389/fneur.2021.817256
double-blind crossover trial in patients with MS. Mult Scler
24. Sheng P, Hou L, Wang X, et al. Efficacy of modafinil on Relat Disord. 2017;11:4-9.
fatigue and excessive daytime sleepiness associated with
neurological disorders: A systematic review and meta- doi: 10.1016/j.msard.2016.10.011
analysis. PLoS One. 2013;8(12):e81802. 35. Broicher SD, Filli L, Geisseler O, et al. Positive effects
of fampridine on cognition, fatigue and depression in
doi: 10.1371/journal.pone.0081802
patients with multiple sclerosis over 2 years. J Neurol.
25. Generali JA, Cada DJ. Amantadine: Multiple sclerosis- 2018;265(5):1016-1025.
related fatigue. Hosp Pharm. 2014;49(8):710-712.
doi: 10.1007/s00415-018-8796-9
doi: 10.1310/hpj4908-710
36. Natsheh JY, DeLuca J, Costa SL, Chiaravalloti ND,
26. Lange R, Volkmer M, Heesen C, Liepert J. Modafinil Dobryakova E. Methylphenidate may improve mental
effects in multiple sclerosis patients with fatigue. J Neurol. fatigue in individuals with multiple sclerosis: A pilot clinical
2009;256(4):645-650. trial. Mult Scler Relat Disord. 2021;56:103273.
doi: 10.1007/s00415-009-0152-7 doi: 10.1016/j.msard.2021.103273
27. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. 37. Kooshiar H, Moshtagh M, Sardar M, Foroughipour M,
Modafinil in treatment of fatigue in multiple sclerosis. Shakeri M, Vahdatinia B. Fatigue and quality of life of
J Neurol. 2002;249(8):983-987. women with multiple sclerosis: A randomized controlled
doi: 10.1007/s00415-002-0765-6 clinical trial. J Sports Med Phys Fitness. 2014;55(6):668-674.
28. Littleton ET, Hobart JC, Palace J. Modafinil for multiple 38. Kerling A, Keweloh K, Tegtbur U, et al. Effects of a short
sclerosis fatigue: Does it work? Clin Neurol Neurosurg. physical exercise intervention on patients with multiple
2010;112(1):29-31. sclerosis (MS). Int J Mol Sci. 2015;16(7):15761-15775.
doi: 10.1016/j.clineuro.2009.09.004 doi: 10.3390/ijms160715761
29. Nourbakhsh B, Revirajan N, Morris B, et al. Safety and 39. Razazian N, Yavari Z, Farnia V, et al. Exercising impacts on
efficacy of amantadine, modafinil, and methylphenidate fatigue, depression, and paresthesia in female patients with
for fatigue in multiple sclerosis: A randomised, placebo- multiple sclerosis. Med Sci Sport Exerc. 2016;48(5):796-803.
controlled, crossover, double-blind trial. Lancet Neurol. doi: 10.1249/MSS.0000000000000834
2021;20(1):38-48.
40. Dehkordi AH. Influence of yoga and aerobics exercise
doi: 10.1016/S1474-4422(20)30354-9 on fatigue, pain and psychosocial status in patients with

30. Pucci E, Brañas Tato P, D’Amico R, Giuliani G, Solari A, multiple sclerosis: A randomized trial. J Sports Med Phys
Taus C. Amantadine for fatigue in multiple sclerosis. Fitness. 2016;56(11):1417-1422.
Cochrane Database Syst Rev. 2007;2007:CD002818. 41. Bulguroglu I, Guclu-Gunduz A, Yazici G, et al. The
doi: 10.1002/14651858.CD002818.pub2 effects of mat pilates and reformer pilates in patients
with multiple sclerosis: A randomized controlled study.
31. Falsafi Z, Tafakhori A, Agah E, et al. Safety and efficacy of
memantine for multiple sclerosis-related fatigue: A pilot NeuroRehabilitation. 2017;41(2):413-422.
randomized, double-blind placebo-controlled trial. J Neurol doi: 10.3233/NRE-162121
Sci. 2020;414:116844.
42. Heine M, Verschuren O, Hoogervorst EL, et al. Does aerobic
doi: 10.1016/j.jns.2020.116844 training alleviate fatigue and improve societal participation
in patients with multiple sclerosis? A randomized controlled
32. de Almeida GM, Scola RH, Ducci RDP, et al. Does oral
salbutamol improve fatigue in multiple sclerosis? A trial. Mult Scler J. 2017;23(11):1517-1526.
pilot placebo-controlled study. Mult Scler Relat Disord. doi: 10.1177/1352458517696596

Volume 3 Issue 2 (2024) 9 doi: 10.36922/an.2576